Skip to main content

Table 4 Worse cytological and histological findings in women living with HIV with persistenta and clearedb high-risk (hr) human papillomavirus (HPV) infection during the study period 2011–2014 (n = 71)

From: Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark – the SHADE

  HPV persistence (n = 31) HPV clearance (n = 40)
Cytology
Normal cytology, n(%) 16 (36.4) 28 (63.6)
ASCUSc, n(%) 0 (0) 1 (100.0)
LSILd, n(%) 9 (50.0) 9 (50.0)
HSILe, n(%) 6 (75.0) 2 (25.0)
Carcinoma, n(%) 0 (0) 0 (0)
Histology
Normal histology, n(%) 3 (30.0) 7 (70.0)
CIN1f, n(%) 4 (66.7) 2 (33.3)
CIN2g, n(%) 3 (75.0) 1 (25.0)
CIN3h, n(%) 2 (100.0) 0 (0)
Carcinoma verified histologically, n(%) 0 (0) 0 (0)
  1. aPersistent = Type-specific persistence was defined as positivity of the same hrHPV type in two separate cervical samples having been taken at least 1 year and at most 2 years after the date the patient was first hrHPV positive; bCleared = having one or more negative results after an hrHPV positive sample; cASCUS atypical cells of undetermined significance; dLSIL = low-grade squamous intraepithelial lesions; eHSIL high-grade squamous intraepithelial lesions including atypical squamous cells - cannot exclude HSIL (ASC-H), atypical glandular cells (AGC) and adenocarcinoma in situ (AIS); fCIN1 cervical intraepithelial neoplasia grade 1; gCIN2 cervical intraepithelial neoplasia grade 2; hCIN3 cervical intraepithelial neoplasia grade 3